* Rocket trial will continue enrollment using JCAR015 with
cyclophosphamide pre-conditioning only
The post BRIEF-Juno Therapeutics to resume JCAR015 phase II rocket trial appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Rocket trial will continue enrollment using JCAR015 with
cyclophosphamide pre-conditioning only
The post BRIEF-Juno Therapeutics to resume JCAR015 phase II rocket trial appeared first on NASDAQ.